Navigation Links
Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations
Date:1/27/2011

ame perspective as Thoratec management, which believes that share-based compensation expense is not directly attributable to the underlying performance of the company’s business operations.

Due to the subjective assumptions used to develop non-cash interest expense related to the accounting for convertible debt instruments that may be settled in cash upon conversion, including partial settlements, in accordance with ASC 470-20, Debt, Thoratec management believes that providing non-GAAP financial measures that exclude such expense allows investors to compare Thoratec’s recurring core business operating results to those of other companies and over multiple periods.  The exclusion also enhances investors’ ability to review Thoratec’s business from the same perspective as Thoratec management.

To enable investors to compare Thoratec’s recurring core business operating results to those of other companies and over multiple periods, Thoratec has excluded the HeartWare transaction costs as they are non-recurring in nature.

There are a number of limitations related to the use of non-GAAP financial measures.  First, non-GAAP financial measures exclude some costs, namely share-based compensation, that are recurring expenses.  Second, share-based compensation is part of an employee’s compensation package and as such may be useful for investors to consider.  Third, the components of costs that we exclude in our non-GAAP financial measures calculations may differ from components that our peer companies exclude when they report their results from operations.

Non-GAAP financial measures should not be considered as a substitute for measures of financial performance in accordance with GAAP. However, these measures may provide additional insight into Thoratec’s financial results. Investors and potential investors are strongly encouraged to review the reconciliation of non-GAAP financial m
'/>"/>

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
3. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
4. Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009
5. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
6. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
7. Thoratec Presentation at Canaccord Adams Conference to be Webcast
8. Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
9. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
10. Thoratec Presentation at Piper Jaffray Conference to be Webcast
11. Thoratec Presentation at Raymond James Conference to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 Baptist Health Lexington is the first ... receive full Atrial Fibrillation with Electrophysiology Services (EPS) Accreditation status ... Atrial fibrillation is the most common cardiac arrhythmia and has ... can lead to stroke and possible death. More than 5 ... have atrial fibrillation and the numbers are rapidly increasing as ...
(Date:12/19/2014)... 2014   Aratana Therapeutics, Inc . (NASDAQ: ... on the licensing, development and commercialization of innovative ... from its pivotal field study of AT-001 (Grapiprant), ... dogs with osteoarthritis.  In the study, dogs receiving ... were statistically significant compared to placebo (p<0.05) at ...
(Date:12/19/2014)... separating membrane market has witnessed robust development with ... albeit as a later starter. In 2012, the size of ... RMB12 billion, with the proportion worldwide soaring to 16.3%. It ... market will continue its growth rate by around 20% in ... jump to roughly RMB25 billion. An integrated membrane ...
Breaking Medicine Technology:Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3
... MELBOURNE, Fla. and BALTIMORE, March 15, 2011 ... venture to innovate, implement and commercialize next generation of ... brings together leading clinicians and advanced engineering technologists. ... ), an international communications and information technology company, and ...
... (Nasdaq: CPHD ) today announced that Glenn Steele, ... Board of Directors at the company,s Annual Meeting of Shareholders ... Steele has been President and Chief Executive Officer of Geisinger ... of Pennsylvania, since 2001.  Before that, Dr. Steele served as ...
Cached Medicine Technology:Harris Corporation and Johns Hopkins Medicine Announce Joint Venture to Develop Innovative Medical Image Management Solutions 2Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors 2Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors 3
(Date:12/19/2014)... B. E. Smith, the only full-service leadership ... retained to lead a national chief financial officer ... The top executive search firm in the healthcare industry, ... healthcare executives into organizations. , Johnson Memorial Hospital ... to the residents of Johnson County and the surrounding ...
(Date:12/19/2014)... If you have ever been unable to breathe, ... you had an arsenal of treatments to battle this ... breathing disorders. Currently, the only proven methods for controlling ... common treatments do exist. At the recent 2014 ... 34 asthma educators responded to a Harmonica Techs survey ...
(Date:12/19/2014)... Irving, Texas (PRWEB) December 19, 2014 ... recently exhibited at the AMSUS Society for Federal ... represent the locum tenens industry to military and ... Staffing attended the National Veterans Small Business Engagement ... “Locum Tenens continues to be a vital solution ...
(Date:12/19/2014)... By Amy Norton ... -- Children born to moms who were exposed to high ... increased risk of developing autism, a U.S. study suggests. ... birth between 1990 and 2002, those exposed to the most ... a baby who later developed autism. And exposure during the ...
(Date:12/17/2014)... While countless companies tempt patients to ... potential dangers of their purchase. Not only is the sale ... doctor, but patients who buy hCG online are typically receiving ... actually no real hCG present. Illegal internet hCG is typically ... safety standards and may contain unknown fillers that can pose ...
Breaking Medicine News(10 mins):Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:Harmonica Techs, Inventors of the Pulmonica®, Unveil New Findings on Complementary Treatments for Asthma 2Health News:Harmonica Techs, Inventors of the Pulmonica®, Unveil New Findings on Complementary Treatments for Asthma 3Health News:Consilium Staffing Increasing Awareness of Locum Tenens through Conference Appearances 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 3
... ... nuts? It,s simple, with a new E-card from Snoring Isn,t Sexy®. Telling someone he or she ... a series of expletives. , ... 27, 2009 -- What,s the perfect way to tell a loved one that their snoring is ...
... , , , TOSU, Saga, ... 4530) and Hisamitsu U.S., Inc. today announced the completion of their ... of Northstar Merger Sub, Inc., a wholly owned subsidiary of Hisamitsu ... Pursuant to the Agreement and Plan of Merger among ...
... , THOUSAND OAKS, Calif., Aug. 27 The ... biggest breakthrough skin l a ser treatment ... . In Los Angeles, beautiful looking skin is a virtue that can ... flawless skin that cosmetic surgery is practically a must for individuals in ...
... drug might slow the destructive lung condition, studies show ... there is no cure for chronic obstructive pulmonary disease ... illness and add years to the lives of sufferers, ... disease of the lungs that is usually brought on ...
... , , , ... MPA Media today announced the launch of a new magazine in ... decisions. , , "MPA Media is fortunate ... by more and more consumers. The most recent research shows that ...
... , , 31 Attorneys General ... , WASHINGTON, Aug. 27 The American Health Care ... letter to Health and Human Services Secretary Kathleen Sebelius, calling for ... Services (CMS,) Nursing Home Five Star Rating System. , ...
Cached Medicine News:Health News:Snoring Isn't Sexy, LLC Announces the Launch of E-cards for Snorers 2Health News:Hisamitsu Pharmaceutical Completes Acquisition of Noven Pharmaceuticals 2Health News:Los Angeles Clinic (laserandveinclinic.com) Offers the Latest Laser Skin Rejuvenation Treatments 2Health News:Treating COPD Early Improves Outcomes 2Health News:Treating COPD Early Improves Outcomes 3Health News:Treating COPD Early Improves Outcomes 4Health News:MPA Media Launches New Chiropractic Publication, Dynamic Chiropractic PracticeINSIGHTS 2Health News:CMS' Five Star Nursing Home Rating System Called Into Question Once Again 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: